Huntington National Bank Trims Stock Holdings in Humana Inc. (NYSE:HUM)

Huntington National Bank cut its holdings in shares of Humana Inc. (NYSE:HUM) by 7.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,459 shares of the insurance provider’s stock after selling 627 shares during the quarter. Huntington National Bank’s holdings in Humana were worth $2,363,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV raised its holdings in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its stake in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. bought a new position in shares of Humana during the third quarter worth about $29,000. Ashton Thomas Securities LLC acquired a new position in Humana in the third quarter worth about $31,000. Finally, Your Advocates Ltd. LLP increased its holdings in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have commented on HUM. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 target price on shares of Humana in a report on Tuesday, October 1st. Royal Bank of Canada decreased their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Stephens reissued an “equal weight” rating and set a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and lifted their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Finally, Wells Fargo & Company dropped their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Price Performance

NYSE HUM opened at $275.67 on Friday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The firm has a market capitalization of $33.19 billion, a PE ratio of 24.42, a P/E/G ratio of 2.29 and a beta of 0.52. The company’s 50 day simple moving average is $283.00 and its 200 day simple moving average is $331.80. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. As a group, equities research analysts forecast that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.